Roger DuMoulin-White, CEO, Theralase Technologies Inc 00:00:00

Share On Facebook Share On Twitter

Theralase Technologies CEO Roger DuMoulin-White joined Steve Darling from Proactive to share details of an update on the company's Phase II Non-Muscle Invasive Bladder Cancer clinical study.

Recent Videos